Modern Vaccines Adjuvants Formulation

18-20 May 2016, Eigtveds Pakhus, Copenhagen, Denmark

  • Increase font size
  • Default font size
  • Decrease font size

Day Two

Final Conference Programme | Thursday 19th May 2016

SESSION 4:
Vaccines and vaccination

Session Moderator: Jean Haensler (Sanofi Pasteur, Lyon, France)

09:00-09:30
‘Optimization of aluminum salts formulations for inactivated poliovirus vaccine dose-sparing’
Livia Brunner (University of Lausanne, Epalinges, Switzerland)

09:30-10:00
‘New adjuvants for FMD vaccines’

Satya Parida (The Pirbright Institute, Guildford, UK)

10:00-10:30
‘A novel vaccination protocol for the induction of local IgA responses against genital C. trachomatis infections – the key role of vaccine-induced Th17 cells’
Frank Follmann (Statens Serum Institut, Copenhagen, Denmark)

10:30-10:45
Wrap-up by Session Moderator

10:45-11:25
Coffee Break & Posters

SESSION 5:
Short Poster Presentations

Session Moderator: Dennis Christensen (Statens Serum Institut, Copenhagen, Denmark)

11:25-11:40 – POSTERS 108 & 109
‘Novel carbohydrate monosulphate ester (CMS) adjuvants with high E/T-ratio and their potentials for single-shot vaccines’
Luuk Hilgers, Peter Paul Platenburg, Anneke Blom, Jeffrey Bajramovic and Han van den Bosch (LiteVax BV, Oss, The Netherlands)

11:40-11:55 – POSTER 103
‘Recombinant lipoimmunogen-based cancer immunotherapy’
Shih-Jen Liu and Chih-Hsiang Leng (National Institute of Infectious Diseases and Vaccinology and National Health Research Institutes, Miaoli, Taiwan)

11:55-12:10 – POSTER 104
‘Recombinant lipoprotein induces broad spectrum of cellular and humoral immune responses without exogenous adjuvant formulation’
Chen-Yi Chiang 1, Shih-Jen Liu 1,2, Chun-Hsiang Hsieh 1, Mei-Yu Chen 1, Jy-Ping Tsai 1, Hsueh-Hung Liu 1, I-Hua Chen 1, Pele Chong 1,2, Chih-Hsiang Leng 1,2 and Hsin-Wei Chen 1,2 (1 National Institute of Infectious Diseases and Vaccinology, Miaoli, Taiwan: 2 National Health Research Institute, Miaoli, Taiwan)

12:10-12:25 – POSTER 113
‘Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria: modulation of CD8 T cell responses and correlates of protection’
Anita Milicic 1, Christine Rollier 2, Choon Kit Tang 1, Karolis Bauza 1, Rhea Longley 3, Adrian V.S. Hill 1 and Arturo Reyes-Sandoval 4 (1 The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK; 2 Oxford Vaccine Group, University of Oxford and the NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, UK; 3 Population Health and Immunity, Walter & Eliza Hall Institute, Parkville, Australia and Mahidol Vivax Research Unit (MVRU), Mahidol University, Bangkok, Thailand; 4 The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK)

12:25-12:35 – POSTER 111
‘Overcoming the cold-chain distribution hurdle: Development of a lyophilized thermostable single vial adjuvanted vaccine against tuberculosis’
Michelle Y. Chan, Alicia M. Schwartz, Dawn M. Fedor, Quinton M. Dowling, Elyse A. Beebe, Liam Kapilow-Cohen, Thomas S. Vedvick, Mark T. Orr, Christopher B. Fox and Ryan M. Kramer
(Infectious Disease Research Institute (IDRI), Seattle, Washington, USA)

12:35-12:45
Wrap-up by Session Moderator

12:45-14:00
Lunch Break & Posters

SESSION 6:
VACCINE & ADJUVANT FORMULATION

Session Moderator: Manmohan Singh (Takeda Vaccines Inc., Morrisville, North Carolina, USA)

14:00-14:30
‘Challenges in development of formulations with adjuvants’
Lakshmi Khandke (Pfizer Vaccine Research, Pearl River, New York, USA)

14:30-15:00
‘Formulation of vaccines/adjuvants with Microfluidizers and upscalable methods’
Yvonne Perrie (Aston University, Aston, Birmingham, UK)

15:00-15:30
‘Formulation of influenza T cell peptides’
Gideon Kersten (Intravacc, Bilthoven, The Netherlands)

15:30-16:00
‘Activation of innate and adaptive immune responses by formulation with a polymer-based combination adjuvant’
S. van Drunen Littel-van den Hurk 1,2, R. Garg 1, I. Sarkar 1,2, V. Gerdts 1,3 and A. Potter 1,3 (1 VIDO-Intervac: 2 Microbiology & Immunology, Veterinary Microbiology: 3 University of Saskatchewan, Saskatoon, Canada)

16:00-16:30
Tea Break & Posters

16:30-17:00
‘Immunostimulating saponin-based nanoparticles: NanoQuil™ adjuvant’

Kefei Hu (Brenntag Biosector, Frederikssund, Denmark)

17:00-17:30
‘Insights to the mechanism of action of the mucosal adjuvant Endocine’
Anna-Karin Maltais (Eurocine Vaccines AB, Solna, Sweden)

17.30-17.40
Wrap-up by Session Moderator

 

MVAF 2016 Delegates

Login details will be supplied after you have registered for the event.


MVAF 2016 Sponsors

  • Brenntag
  • Vaxart
  • Sanofi Pasteur
  • Seppic
  • NanoTemper Technologies
  • IntraVacc
  • IDRI
  • EVI
  • hVIVO
  • Inovio
  • Mucosis
  • Aldevron
  • Bioaster
  • Pfizer
  • DNAvaccine.com
  • NatureGeneTherapy.com
  • CureVac

MVAF 2016 Downloads

MVAF 2016 Leaflet

MVAF 2016 Mailing List

Name
E-mail Address
What is 3+2-1?